The seven defendants were allegedly involved through a variety of corporate entities, including as owners of Tesis Labs, a parent company that owned and operated genetic testing labs, according to a Sept. 24 Justice Department news release.
The seven defendants are:
- Ronald King, 51, of Bangor, Maine,
- Victor Roiter, 55, of Sunny Isles Beach, Fla.
- Tina Wellman, 51, of Mayfield, N.Y.
- Adam Shorr, 55, of Dunedin, Fla.
- Robert O’Sullivan, 55, of Lake Sherwood, Calif.
- Bradley Edson, 66, of Mesa, Ariz.
- John Gautereaux, 59, of Temecula, Calif.
Mr. King, Mr. Roiter, Ms. Wellman and Mr. Shorr are accused of conspiring to defraud Medicare and Colorado’s Medicaid program through several means, including paying kickbacks and bribes to purported marketing companies for referrals for fraudulent and medically unnecessary genetic testing, according to the release.
All seven are accused of participating in a scheme to offer and pay bribes and kickbacks in connection with healthcare benefit programs, including Medicare, Medicaid and private payers, according to the release. They allegedly agreed to pay marketers to solicit patients to participate in unnecessary genetic testing and to obtain physicians’ signatures on testing order forms.
Mr. King, Mr. Roiter and Ms. Wellman are also accused of conspiring to launder the proceeds of the alleged schemes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
